Literature DB >> 10841593

Cigarette consumption and sales of nicotine replacement products.

T Hu1, H Y Sung, T E Keeler, M Marciniak.   

Abstract

BACKGROUND: The first nicotine replacement product, Nicorette Gum, was marketed in 1984 as an adjuvant to help smokers quit smoking. In 1992, sales of nicotine patches were begun. Before 1996, nicotine gums and nicotine patches were prescribed by physicians and supplemented with behavioural counselling. Since 1996, nicotine gums and patches became available over the counter.
OBJECTIVES: To examine the effect of sales of nicotine replacement products on national cigarette consumption.
DESIGN: National time series quarterly cigarette consumption, sales of nicotine gums and patches data between 1976 and 1998 are used to estimate a time series autoregressive moving average intervention model. PARTICIPANTS: National reported statistics. MAIN OUTCOME MEASURES: Per capita cigarette sales.
RESULTS: A 10% increase in sales of nicotine replacement products will lead to a 0.04% reduction in cigarette sales. The model indicates that a 0.076% reduction in cigarette consumption is associated with the availability of nicotine patches after 1992. The over the counter dummy variable (after 1996) has a negative sign, but is not significant, perhaps due to only a few quarters of data in the study period.
CONCLUSIONS: Nicotine replacement products (nicotine gums and nicotine patches) play a significant role in reducing cigarette consumption, in addition to the negative effect of increasing cigarette price and the overall trend of declining cigarette consumption (as reflected by the time trend variable). The findings of this study suggest that additional efforts for promoting sales of nicotine replacement products will be another effective alternative to discouraging cigarette consumption.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841593      PMCID: PMC1766286          DOI: 10.1136/tc.9.suppl_2.ii60

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  14 in total

1.  Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study.

Authors:  D M Daughton; S A Heatley; J J Prendergast; D Causey; M Knowles; C N Rolf; R A Cheney; K Hatlelid; A B Thompson; S I Rennard
Journal:  Arch Intern Med       Date:  1991-04

2.  Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.

Authors:  J Cromwell; W J Bartosch; M C Fiore; V Hasselblad; T Baker
Journal:  JAMA       Date:  1997-12-03       Impact factor: 56.272

3.  Treating tobacco addiction--nicotine or no nicotine?

Authors:  N L Benowitz
Journal:  N Engl J Med       Date:  1997-10-23       Impact factor: 91.245

4.  The emerging market for long-term nicotine maintenance.

Authors:  K E Warner; J Slade; D T Sweanor
Journal:  JAMA       Date:  1997-10-01       Impact factor: 56.272

5.  A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation.

Authors:  P Tønnesen; J Nørregaard; K Simonsen; U Säwe
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

6.  Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.

Authors:  M Kornitzer; M Boutsen; M Dramaix; J Thijs; G Gustavsson
Journal:  Prev Med       Date:  1995-01       Impact factor: 4.018

7.  Nicotine patch use in the general population: results from the 1993 California Tobacco Survey.

Authors:  J P Pierce; E Gilpin; A J Farkas
Journal:  J Natl Cancer Inst       Date:  1995-01-18       Impact factor: 13.506

8.  Predicting smoking cessation. Who will quit with and without the nicotine patch.

Authors:  S L Kenford; M C Fiore; D E Jorenby; S S Smith; D Wetter; T B Baker
Journal:  JAMA       Date:  1994-02-23       Impact factor: 56.272

Review 9.  Tobacco dependence and the nicotine patch. Clinical guidelines for effective use.

Authors:  M C Fiore; D E Jorenby; T B Baker; S L Kenford
Journal:  JAMA       Date:  1992-11-18       Impact factor: 56.272

10.  Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling.

Authors:  K Fiscella; P Franks
Journal:  JAMA       Date:  1996-04-24       Impact factor: 56.272

View more
  4 in total

Review 1.  Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell).

Authors:  Bertrand Dautzenberg; Mitchell Nides; Jean-Luc Kienzler; Anne Callens
Journal:  BMC Clin Pharmacol       Date:  2007-10-08

2.  Nicotine impairs intra-substance tendon healing after full thickness injury in a rat model.

Authors:  Adnan N Cheema; Joseph B Newton; James F Boorman-Padgett; Stephanie N Weiss; Courtney A Nuss; Daniel J Gittings; Daniel C Farber; Louis J Soslowsky
Journal:  J Orthop Res       Date:  2018-11-30       Impact factor: 3.494

3.  Lessons and Guidance from the Special Issue on Electronic Cigarette Use and Public Health.

Authors:  Walton Sumner; Konstantinos Farsalinos
Journal:  Int J Environ Res Public Health       Date:  2018-06-26       Impact factor: 3.390

Review 4.  New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

Authors:  Emma Beard; Lion Shahab; Damian M Cummings; Susan Michie; Robert West
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.